Veracyte, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	150.3M	139.1M	140.6M	131.9M	130.2M	114.5M	118.6M	115.9M
Cost of Goods Sold	41.2M	38.5M	36.0M	40.6M	40.4M	35.0M	39.9M	36.9M
Gross Profit	109.1M	100.6M	104.7M	91.3M	89.8M	79.5M	78.8M	79.0M
R&D Expenses	29.4M	27.1M	20.8M	16.0M	16.3M	17.7M	19.3M	17.6M
Operating Expenses	86.3M	76.7M	78.7M	68.3M	95.0M	76.6M	74.6M	67.0M
Operating Income	21.8M	23.8M	25.9M	22.9M	-5.3M	2.9M	4.2M	12.0M
Other Income / Gains	4.7M	6.1M	14.7M	-4.1M	6.5M	4.5M	-732K	4.8M
Net Income	25.5M	28.7M	41.1M	19.1M	-980K	7.0M	5.1M	15.2M
EPS (Diluted)	0.32	0.36	0.52	0.24	-0.013	0.09	0.07	0.20
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.726	0.723	0.744	0.692	0.69	0.695	0.664	0.682
General And Administrative Expenses	27.4M	23.7M	1.4M	43.2M	13.8M	52.3M	47.1M	40.5M
Selling And Marketing Expenses	28.3M	27.2M	42.9M	7.5M	43.0M	6.8M	7.7M	6.8M
Selling General And Administrative Expenses	55.7M	50.8M	44.3M	50.7M	56.7M	59.2M	54.8M	47.2M
Other Expenses	1.2M	-1.2M	13.6M	1.6M	22.0M	-277K	482K	2.2M
Cost And Expenses	127.5M	115.2M	114.7M	108.9M	135.4M	111.6M	114.5M	103.8M
Interest Income	-3.5M	3.5M	3.5M	3.5M	2.9M	2.8M	2.9M	2.9M
Interest Expense	0	0	0	0	0	0	0	1K
Depreciation And Amortization	-5.4M	5.4M	5.3M	5.3M	5.5M	5.4M	6.3M	5.9M
Ebitda	21.1M	35.4M	45.9M	24.2M	6.7M	6.5M	9.7M	22.7M
Ebitdaratio	0.14	0.255	0.327	0.183	0.052	0.057	0.082	0.196
Operating Income Ratio	0.145	0.171	0.184	0.174	-0.04	0.025	0.035	0.104
Income Before Tax	26.5M	30.0M	40.6M	18.9M	1.3M	7.4M	3.4M	16.8M
Income Before Tax Ratio	0.176	0.216	0.289	0.143	0.01	0.065	0.029	0.145
Income Tax Expense	1.0M	1.3M	-515K	-248K	2.2M	381K	-1.7M	1.7M
Net Income Ratio	0.17	0.206	0.293	0.145	-0.008	0.062	0.043	0.131
Epsdiluted	0.31	0.35	0.50	0.24	-0.013	0.088	0.06	0.19
Weighted Average Shs Out	79.8M	79.5M	79.2M	78.7M	78.2M	78.0M	77.6M	77.0M
Weighted Average Shs Out Dil	81.8M	81.3M	81.4M	79.7M	79.9M	80.1M	79.9M	78.5M